{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:40:21Z","timestamp":1787740821824,"version":"build-2784847793"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,31]]},"abstract":"<jats:p>Acute myeloid leukemia (AML), an uncommonly low 5-year survival and high mortality rate, is a potentially catastrophic diagnosed subtype of leukemia. The development of new prognostic markers is urgently needed to guide its treatment. Necroptosis is a newly defined biological process for regulating cell death, and previous studies have confirmed that the abnormality of the physical function can lead to multiple malignancies. Here, we performed necroptosis-related genes (NRGs) to build a predictive model in the Cancer Genome Atlas (TCGA)-AML patients, thus exploring the correlation between the NRG prognosis signature (NRG score) of this model and immune infiltration, pathway activity, clinical features, and immunotherapy. Besides, we computed the statistical measure Spearman rank correlation between the NRG score and the Log IC50 values of therapeutic agents. Subsequently, we divided the TCGA-AML cohort into 2 groups, one with high scores and the other with low scores depending on the model score. AML patients with high NRG scores exhibited a lower estimated overall survival (OS) rate than those with low NRG scores, which was confirmed in the validation set. The prognostic value of the constructed NRG signature to the AML, independent of other variables, was demonstrated by uni- and multivariate stepwise regression analysis. When comparing the infiltrating states of specialized cells associated with immune system from the 2 groups, B cells naive, Plasma cells, and monocytes represented significant differences among various subgroups of samples. Moreover, the 30 hallmark-related pathways related to necroptosis characteristics were remarkably different between the high\/low NRG score groups. And patients showed remarkable NRG score distribution in clinical features of bone marrow lymphocyte, category, and FAB classifications. Besides, we found that the BIRB0796, VX680, Vorinostat, and Axitinib positively related with NRG score, whereas CI. 1040, PD. 0325901, Z.L LNle. CHO, and AZD6244 negatively correlated with the NRG score. These drugs may provide a reference for subsequent treatment.<\/jats:p>","DOI":"10.1097\/md.0000000000038432","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T18:21:14Z","timestamp":1717179674000},"page":"e38432","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Construction and validation of a necroptosis-related prognostic signature in acute myeloid leukemia"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6940-631X","authenticated-orcid":false,"given":"Yu-Qing","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Key Laboratory of Laboratory Medicine, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Innovation Team of Clinical Laboratory and Diagnosis, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, Yunnan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Key Laboratory of Laboratory Medicine, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Innovation Team of Clinical Laboratory and Diagnosis, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, Yunnan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Key Laboratory of Laboratory Medicine, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Innovation Team of Clinical Laboratory and Diagnosis, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, Yunnan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Key Laboratory of Laboratory Medicine, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Innovation Team of Clinical Laboratory and Diagnosis, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, Yunnan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Key Laboratory of Laboratory Medicine, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Innovation Team of Clinical Laboratory and Diagnosis, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, Yunnan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Key Laboratory of Laboratory Medicine, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Innovation Team of Clinical Laboratory and Diagnosis, the First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P.R. China"},{"name":"Yunnan Province Clinical Research Center for Laboratory Medicine, Kunming, Yunnan, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bjh.15032","article-title":"Advances in targeted therapy for acute myeloid leukaemia.","volume":"180","author":"Kayser","year":"2018","journal-title":"Br J Haematol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants.","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.bbmt.2019.04.025","article-title":"Risk stratification and prognosticators of acute myeloid leukemia with myelodysplasia-related changes in patients undergoing allogeneic stem cell transplantation: a retrospective study of the adult acute myeloid leukemia working group of the Japan society for hematopoietic cell transplantation.","volume":"25","author":"Harada","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/ATVBAHA.119.313353","article-title":"Tyrosine kinase inhibitors in leukemia and cardiovascular events: from mechanism to patient care.","volume":"40","author":"Manouchehri","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy.","volume":"18","author":"Gong","year":"2019","journal-title":"Mol Cancer"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"e2905","DOI":"10.1038\/cddis.2017.286","article-title":"Necroptosis in neurodegenerative diseases: a potential therapeutic target.","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","article-title":"Necroptosis and tumor progression.","volume":"8","author":"Yan","year":"2022","journal-title":"Trends Cancer"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"105297","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications.","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol Res"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1631\/jzus.B1900160","article-title":"Complex roles of necroptosis in cancer.","volume":"20","author":"Zhu","year":"2019","journal-title":"J Zhejiang Univ Sci B"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-018-0976-z","article-title":"Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia.","volume":"37","author":"Huang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"10258","DOI":"10.1038\/s41598-020-66986-8","article-title":"ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications.","volume":"10","author":"Yi","year":"2020","journal-title":"Sci Rep"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry.","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.aab4082","article-title":"Somatic mutation in cancer and normal cells.","volume":"349","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death.","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.7150\/ijms.76480","article-title":"Ferroptosis: a new promising target for ovarian cancer therapy.","volume":"19","author":"Zhao","year":"2022","journal-title":"Int J Med Sci"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis.","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11523-020-00711-3","article-title":"Targeting apoptosis in acute myeloid leukemia: current status and future directions of BCL-2 inhibition with venetoclax and beyond.","volume":"15","author":"Choi","year":"2020","journal-title":"Target Oncol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","article-title":"Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.","volume":"1","author":"Holler","year":"2000","journal-title":"Nat Immunol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pathol-052016-100247","article-title":"Necroptosis: mechanisms and relevance to disease.","volume":"12","author":"Galluzzi","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-\u03baB by TNF family cytokines.","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin Immunol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2013.10.018","article-title":"Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.","volume":"344","author":"Chromik","year":"2014","journal-title":"Cancer Lett"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"339ra69","DOI":"10.1126\/scitranslmed.aad3099","article-title":"The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.","volume":"8","author":"Brumatti","year":"2016","journal-title":"Sci Transl Med"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1111\/jcmm.17494","article-title":"Identification of necroptosis-related gene signature and characterization of tumour microenvironment infiltration in non-small-cell lung cancer.","volume":"26","author":"Dai","year":"2022","journal-title":"J Cell Mol Med"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12957-022-02802-z","article-title":"Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.","volume":"20","author":"Sun","year":"2022","journal-title":"World J Surg Oncol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"108714","DOI":"10.1016\/j.biopha.2019.108714","article-title":"Extracellular HMGB1 prevents necroptosis in acute myeloid leukemia cells.","volume":"112","author":"Liu","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11357-019-00131-w","article-title":"The potential role of necroptosis in inflammaging and aging.","volume":"41","author":"Royce","year":"2019","journal-title":"GeroScience"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/febs.14738","article-title":"Necroptosis directly induces the release of full-length biologically active IL-33 in vitro and in an inflammatory disease model.","volume":"286","author":"Shlomovitz","year":"2019","journal-title":"FEBS J"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood-2008-04-152686","article-title":"Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.","volume":"113","author":"Mhyre","year":"2009","journal-title":"Blood"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1749-6632.2009.04731.x","article-title":"Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.","volume":"1171","author":"Reuter","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41375-019-0623-5","article-title":"Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes.","volume":"34","author":"Montalban-Bravo","year":"2020","journal-title":"Leukemia"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41388-022-02187-z","article-title":"Role of fibrosarcoma-induced CD11b(+) myeloid cells and tumor necrosis factor-\u03b1 in B cell responses.","volume":"41","author":"Wang","year":"2022","journal-title":"Oncogene"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"830021","DOI":"10.3389\/fimmu.2022.830021","article-title":"Rapid generation of TCR and CD8\u03b1\u03b2 transgenic virus specific T cells for immunotherapy of leukemia.","volume":"13","author":"Bajwa","year":"2022","journal-title":"Front Immunol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40364-021-00302-y","article-title":"Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome.","volume":"9","author":"Huang","year":"2021","journal-title":"Biomark Res"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bcmd.2019.04.008","article-title":"Monocytes-neutrophils-ratio as predictive marker for failure of first induction therapy in AML.","volume":"77","author":"Mika","year":"2019","journal-title":"Blood Cells Mol Dis"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"102300","DOI":"10.1016\/j.jbc.2022.102300","article-title":"An immunogenic cell injury module for the single-cell multiplexed activity metabolomics platform to identify promising anti-cancer natural products.","volume":"298","author":"Balsamo","year":"2022","journal-title":"J Biol Chem"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.stem.2019.05.019","article-title":"TNF-\u03b1 coordinates hematopoietic stem cell survival and myeloid regeneration.","volume":"25","author":"Yamashita","year":"2019","journal-title":"Cell Stem Cell"},{"key":"R42-20250503","first-page":"1961","article-title":"MEK inhibitor CI-1040 induces apoptosis in acute myeloid leukemia cells in vitro.","volume":"20","author":"Wei","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00109-012-0886-z","article-title":"Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for \u201cvertical\u201d and \u201clateral\u201d combination strategies.","volume":"90","author":"Ricciardi","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.leu.2404647","article-title":"ZD6474 induces growth arrest and apoptosis of human leukemia cells, which is enhanced by concomitant use of a novel MEK inhibitor, AZD6244.","volume":"21","author":"Nishioka","year":"2007","journal-title":"Leukemia"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/leu.2011.50","article-title":"GSI-I (Z-LLNle-CHO) inhibits \u03b3-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.","volume":"25","author":"Meng","year":"2011","journal-title":"Leukemia"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/13543784.2011.542750","article-title":"Vorinostat in acute myeloid leukemia and myelodysplastic syndromes.","volume":"20","author":"Prebet","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.drudis.2021.10.011","article-title":"Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: a revisited review of apoptosis, autophagy-dependent cell death and necroptosis.","volume":"27","author":"Liu","year":"2022","journal-title":"Drug Discov Today"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1038\/s41467-020-16819-z","article-title":"A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction.","volume":"11","author":"Hildebrand","year":"2020","journal-title":"Nat Commun"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"a030320","DOI":"10.1101\/cshperspect.a030320","article-title":"DNMT3A in leukemia.","volume":"7","author":"Brunetti","year":"2017","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:13:42Z","timestamp":1746317622000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":49,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038432","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}